Toxicological analysis points to a lower tolerable daily intake of melamine in food

Regulatory Toxicology and Pharmacology

Volumn 55, Issue 1, 2009, Pages 13-16

  Hsieh, D P H ^a   Chiang, C F ^a   Chiang, P H ^b   Wen, C P ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Food safety; Health risk assessment; Melamine; Tolerable daily intake (TDI)

Indexed keywords

MELAMINE;

ARTICLE; BLADDER STONE; DAIRY PRODUCT; FOOD AND DRUG ADMINISTRATION; FOOD CONTAMINATION; FOOD INTAKE; FOOD POISONING; FOOD QUALITY; FOOD SAFETY; HUMAN; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; VULNERABLE POPULATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; HUMANS; MAXIMUM ALLOWABLE CONCENTRATION; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT; TRIAZINES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 69249229537     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2009.05.004     Document Type: Article

References (12)

1. Clewell H., Teeguarden J., McDonald T., Sarangapani R., Lawrence G., Gentry R., Covington T., and Shipp A. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Crit. Rev. Toxicol. 32 (2002) 329-389
2. Coe F.L., Evan A., and Worcester E. Kidney stone disease. J. Clin. Invest. 115 (2005) 2598-2608
3. Dourson M.L., Felter S.P., and Robinson D. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 24 (1996) 108-120
4. EPA, 2005. Guidelines for Carcinogen Risk Assessment, EPA/630/P-03/001F. Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=116283).
5. EPA, 2006. A Framework for Assessing Health Risks of Environmental Exposures to Children, EPA/600/R-05/093F. Available from: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=158363.
6. EPA, 2008. Benchmark Dose Software (BMDS). Available from: http://www.epa.gov/ncea/bmds/.
7. FDA, 2007. Interim Melamine and Analogues Safety/Risk Assessment, May 25. Available from: http:// www.cfsan.fda.gov/~dms/melamra.html.
8. FDA, 2008. Interim Safety and Risk Assessment of Melamine and its Analogues in Food for Humans, November 28. Available from: http://www.cfsan.fda.gov/~dms/melamra3.html#ftn1).
9. Haber, L., Hack, C.E., Zhao, J., 2005. Meeting materials for a peer consultation on a draft framework to evaluate whether the default uncertainty factor for human kinetic variability is adequate for protecting children, Draft Framework, TERA. Available from: http://www.tera.org/peer/AdultChildTK/HKAdultChildFramework.pdf.
10. NTP, 1983. Carcinogenesis bioassay of melamine in F344/N rats and B6C3F1 mice (feed study), NTP Tech. Rep. Ser. No. 245.
11. WHO, 2008a. Melamine-contamination Event, China, 2008, Report from Expert Meeting to Review Toxicological Aspects of Melamine and Cyanuric Acid, Held in Collaboration with FAO and Supported by Health Canada, Ottawa, Canada, 1-4 December 2008. Available from: http://www.who.int/foodsafety/fs_management/infosan_events/en/index.html .
12. WHO, 2008b. Melamine and Cyanuric acid: Toxicity, Preliminary Risk Assessment and Guidance on Levels in Food, 25 September 2008-Updated 30 October 2008. Available from: http://www.who.int/foodsafety/fs_management/Melamine.pdf.